Compositions and methods relating to the daptomycin biosynthetic gene cluster
First Claim
1. An isolated nucleic acid molecule comprising a nucleic acid sequence encoding a daptomycin non-ribosomal peptide synthetase (NRPS) or subunit thereof from Streptomyces roseosporus, wherein the nucleic acid molecule encodes DptBC and wherein said nucleic acid molecule is not pRHB159.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention provides nucleic acid molecules comprising all or a part of a daptomycin biosynthetic gene cluster. The daptomycin biosynthetic gene cluster may be derived from Streptomyces, preferably from S. roseosporus. The invention also provides other nucleic acid molecules from S. roseosporus. The invention further provides polypeptides encoded by the nucleic acid molecules, antibodies that specifically bind to the polypeptides, and methods of using the nucleic acid molecules, polypeptides and antibodies to produce daptomycin and other compounds.
23 Citations
73 Claims
- 1. An isolated nucleic acid molecule comprising a nucleic acid sequence encoding a daptomycin non-ribosomal peptide synthetase (NRPS) or subunit thereof from Streptomyces roseosporus, wherein the nucleic acid molecule encodes DptBC and wherein said nucleic acid molecule is not pRHB159.
-
5. An isolated nucleic acid molecule that encodes a daptomycin NRPS or subunit thereof, wherein the isolated nucleic acid molecule selectively hybridizes to a reference nucleic acid molecule that encodes a daptomycin NRPS or subunit thereof, wherein the reference nucleic acid molecule comprises a nucleic acid sequence selected from the group consisting of:
-
a) the nucleic acid sequence of dptBC;
(b) a nucleic acid sequence encoding the amino acid sequence of DptBC;
(c) a nucleic acid sequence encoding the amino acid sequence SEQ ID NO;
11; and
(d) the nucleic acid sequence SEQ ID NO;
12;
wherein said nucleic acid molecule is not pRHB159. - View Dependent Claims (6)
-
-
7. An isolated nucleic acid molecule that encodes a daptomycin NRPS or subunit thereof, wherein the isolated nucleic acid molecule comprises a nucleic acid sequence that has at least 50% sequence identity to a nucleic acid sequence selected from the group consisting of:
-
(a) the nucleic acid sequence of dptBC;
(b) a nucleic acid sequence encoding the amino acid sequence of DptBC;
(c) a nucleic acid sequence encoding the amino acid sequence SEQ ID NO;
11; and
(d) the nucleic acid sequence SEQ ID NO;
12;
wherein said nucleic acid molecule is not pRHB159. - View Dependent Claims (8, 9, 10, 11, 12)
-
-
13. An isolated nucleic acid molecule that encodes a daptomycin NRPS or subunit thereof, wherein the isolated nucleic acid molecule is an allelic variant of a nucleic acid molecule that comprises a nucleic acid sequence selected from the group consisting of:
-
(a) the nucleic acid sequence of dptBC;
(b) a nucleic acid sequence encoding the amino acid sequence of DptBC;
(c) a nucleic acid sequence encoding the amino acid sequence SEQ ID NO;
11; and
(d) the nucleic acid sequence SEQ ID NO;
12.
-
-
14. An isolated nucleic acid molecule comprising a part of a nucleic acid sequence, wherein said part is at least 14 nucleotides, selected from the group consisting of:
-
(a) a nucleic acid sequence encoding the amino acid sequence of a polypeptide comprising amino acids 5003 to 5007 Of SEQ ID NO;
11; and
(b) a nucleic acid sequence comprising nucleotides 68350 to 68364 of SEQ ID NO;
12;
wherein said nucleic acid molecule is not pRHB159. - View Dependent Claims (15, 16, 17, 18, 19, 20, 21, 30)
-
-
28. An isolated polypeptide comprising an amino acid sequence selected from the group consisting of
(a) the amino acid sequence encoded by the nucleic acid sequence of dptBC; -
(b) the amino acid sequence of DptBC;
(c) the amino acid sequence of SEQ ID NO;
11; and
(d) the amino acid sequence encoded by the nucleic acid sequence SEQ ID NO;
12. - View Dependent Claims (31, 32, 33, 34, 35, 36)
-
-
38. A method to produce daptomycin comprising the steps of
(a) introducing a nucleic acid molecule comprising SEQ ID NO: - 1 in a host cell; and
(b) culturing the host cell under conditions in which daptomycin is produced. - View Dependent Claims (39, 40, 41, 42, 43, 44, 45, 46, 47)
- 1 in a host cell; and
-
48. A method to increase the production of daptomycin by a cell comprising the steps of
(a) providing a host cell that expresses daptomycin; -
(b) introducing a nucleic acid molecule into a neutral site of a chromosome of said host cell, wherein the introduction of the nucleic acid molecule results in increased production of daptomycin by a cell compared to the cell without the nucleic acid molecule; and
(c) culturing the host cell under conditions in which daptomycin is produced;
wherein the nucleic acid molecule comprises a nucleic acid sequence selected from the group consistng of (i) the nucleic acid sequence of dptBC;
(ii) a nucleic acid sequence encoding the amino acid sequence of DptBC;
(iii) a nucleic acid sequence encoding the amino acid sequence SEQ ID NO;
11; and
(iv) the nucleic acid sequence SEQ ID NO;
12. - View Dependent Claims (49)
-
-
50. A nucleic acid molecule comprising a nucleic acid sequence selected from the group consisting of SEQ ID NOS:
- 24, 54, 74, 94, 98 and 100, or encoding a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NOS;
93, 97 and 99;
wherein said nucleic acid molecule is not pRHB160, pRHB166, pRHB613, pRHB614, or pRHB680.
- 24, 54, 74, 94, 98 and 100, or encoding a polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NOS;
-
51. A polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOS:
- 93, 97, and 99;
or encoded by a nucleic acid molecule selected from the group consisting of SEQ ID NOS;
24, 54, 74, 94 98 and 100. - View Dependent Claims (54)
- 93, 97, and 99;
-
52. A nucleic acid molecule comprising a nucleic acid sequence selected from the group consisting of SEQ ID NOS:
- 105, 107, 109, 111, 113, 115, 117, 119, 121, 123, 125, 127, 129, 131, 133 and 135;
or encoding a polypeptide having an amino acid sequence selected from the group consisting of 104, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, 132, 134 and 136;
wherein said nucleic acid molecule is not pRHB174.
- 105, 107, 109, 111, 113, 115, 117, 119, 121, 123, 125, 127, 129, 131, 133 and 135;
-
53. A polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NOS:
- 104, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, 132, 134 and 136;
or encoded by a nucleic acid molecule selected from the group consisting of SEQ ID NOS;
102, 105, 107, 109, 111, 113, 115, 117, 119, 121, 123, 125, 127, 129, 131, 133 and 135.
- 104, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, 132, 134 and 136;
-
55. A method for producing a lipopeptide or peptide core thereof, comprising the steps of
(a) providing a cell comprising an NRPS gene cluster other than the daptomycin biosynthetic gene cluster in a cell; -
(b) introducing into the cell at least one gene that encodes all or a part of the NRPS from the daptomycin biosynthetic gene cluster; and
(c) culturing the cell under conditions in which the lipopeptide or peptide core thereof is produced. - View Dependent Claims (57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70)
-
-
56. A method for producing a lipopeptide or peptide core thereof, comprising the steps of
(a) providing a cell comprising a daptomycin biosynthetic gene cluster in a cell; -
(b) introducing into the cell at least one other gene that encodes all or a part of an NRPS from an NRPS gene cluster other than the daptomycin biosynthetic gene cluster; and
(c) culturing the cell under conditions in which the lipopeptide or peptide core thereof is produced.
-
-
71. A method for producing a lipopeptide or peptide core thereof, comprising the steps of
(a) providing a cell comprising a daptomycin biosynthetic gene cluster in a cell; -
(b) modifying or exchanging one or more modules of the daptomycin biosynthetic gene cluster to alter at least one amino acid directed for incorporation by the gene cluster;
(c) introducing into the cell at least one other gene that encodes all or a part of an NRPS from the daptomycin biosynthetic gene cluster or another NRPS gene cluster; and
(d) culturing the cell under conditions in which the lipopeptide or peptide core thereof is produced.
-
-
72. A method for producing a lipopeptide or peptide core thereof, comprising the steps of
(a) providing a cell comprising an NRPS gene cluster in a cell; -
(b) introducing a daptomycin biosynthetic gene cluster in a cell;
(c) modifying or exchanging one or more modules of the daptomycin biosynthetic gene cluster to alter at least one amino acid directed for incorporation by the gene cluster; and
(d) culturing the host cell under conditions in which the lipopeptide or peptide core thereof is produced.
-
-
73. A method for producing a lipopeptide or peptide core thereof, comprising the steps of
(a) providing a cell comprising an NRPS gene cluster in a cell; -
(b) providing a daptomycin biosynthetic gene cluster in a cell;
(c) modifying or exchanging one or more modules of the daptomycin biosynthetic gene cluster to alter at least one amino acid directed for incorporation by the gene cluster;
(d) introducing the modified daptomycin biosynthetic gene cluster into the cell; and
(e) culturing the host cell under conditions in which the lipopeptide or peptide core thereof is produced.
-
Specification